staurosporine has been researched along with spironolactone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gekle, M; Oberleithner, H; Silbernagl, S | 1 |
| Lai, M; Macleod, M; Seckl, J | 1 |
2 other study(ies) available for staurosporine and spironolactone
| Article | Year |
|---|---|
The mineralocorticoid aldosterone activates a proton conductance in cultured kidney cells.
Topics: Aldosterone; Animals; Anti-Bacterial Agents; Cell Line; Dogs; Enzyme Inhibitors; Hydrogen-Ion Concentration; Imidazoles; Kidney; Kinetics; Macrolides; Meglumine; Membrane Potentials; Naphthalenes; Pertussis Toxin; Protein Kinase C; Protein Serine-Threonine Kinases; Proton Pump Inhibitors; Proton-Translocating ATPases; Sodium-Hydrogen Exchangers; Spironolactone; Staurosporine; Tetradecanoylphorbol Acetate; Virulence Factors, Bordetella; Zinc | 1997 |
Overexpression of the mineralocorticoid receptor protects against injury in PC12 cells.
Topics: Aldosterone; Animals; Binding, Competitive; Cell Death; Cell Hypoxia; Cell Survival; Cytoprotection; Drug Interactions; Enzyme Inhibitors; Gene Expression Regulation; Mineralocorticoid Receptor Antagonists; PC12 Cells; Rats; Receptors, Mineralocorticoid; Spironolactone; Staurosporine; Transfection; Tritium | 2005 |